Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.

There was an interesting trend toward less pneumonectomy and more minimally invasive procedures performed in the Nivo + CT study arm. 11 As such, our surgical results of NEOSTAR Arm C with Nivo + CT are overall comparable to CheckMate 816 with high resectability and R0 rates (>90%), although our study is a small, single-center study in the United States.

also in 1,783 other papers